［1］Wardwell NR, Massion PP. Novel strategies for the early detection and prevention of lung cancer\[J\]. Semin Oncol, 2005, 32(3): 259-268.［2］Sheppard P, Kindsvogel W, Xu W, et al.IL28, IL29 and their class Ⅱ cytokine receptor IL28R\[J\]. Nat Immunol, 2003, 4(1): 63-68.［3］Li W, LewisAntes A, Huang J, et al.Regulation of apoptosis by type Ⅲ interferons\[J\].Cell Prolif, 2008, 41(6):960-979.［4］Sato A, Ohtsuki M, Hata M, et al. Antitumor activity of IFNλ in murine tumor models\[J\]. J Immunol, 2006,176(12):7686-7694.［5］Yan Y, Zhang J, Liu Y, et al. Inhibition of lung adenocarcinoma transfected with interleukin 28A recombinant adenovirus(AdmIFNλ2) in vivo\[J\]. Cancer Biother Radiopharm, 2013, 28(2):124-130.［6］Pepper MS, Vassalli JD, Orci L, et al. Biphasic effect of transforming growth factorβ1 on in vitro angiogenesis\[J\]. Exp Cell Res, 1993, 204(2): 356-363.［7］冯保印，刘章锁，于善法. TGFβ在非小细胞肺癌中的表达及意义\[J\]. 河南医学研究，2008，17(3):213-215.［8］李威，吴昊，张彤. Ⅲ型干扰素的抗肿瘤作用\[J\]. 现代生物医学进展，2012，12 (17): 3370-3373.［9］朱红，项锋钢. TGFβ1mRNA在肺腺癌组织中的表达\[J\]. 青岛大学医学院学报，2007，43(5): 419-423.
2016, Vol. 26 
